transitioning from semaglutide to tirzepatide Switching Tirzepatide: A Provider's Guide How to Switch from Tirzepatide

At 20mg/mL concentration with the 1.0mL reconstitution, each unit on your syringe delivers exactly 200mcg

The most commonly reported adverse events (observed in greater than 5% of clinical trial participants) were nausea, diarrhea, vomiting, constipation, abdominal pain, dyspepsia, injection-site reactions, fatigue, hypersensitivity reactions, eructation, hair loss and gastroesophageal reflux disease

The American College of Obstetricians and Gynecologists (ACOG) similarly advises that GLP-1 receptor agonist medications, including tirzepatide, should generally be discontinued before conception due to limited safety data in human pregnancy

(2013) 25:346e255

Postprandial hypoglycemia in children after gastric surgery: clinical characterization and pathophysiology

Uh, its important to think about the route and tailoring the choice to the patient